Strategic transaction supports the advancement of Decoy’s rapid computational design and manufacturing of innovative peptide conjugate therapeutics through its IMP3ACT™ platform Combined company has pro forma cash of $14 million following merger and closing of recent public offering HOUSTON and CAMBRIDGE, Mass., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals ( SLRX ) (“Salarius” or the “Company”) and Decoy Therapeutics...

08:17 AM EST, 11/13/2025 (MT Newswires) -- First Mining Gold ( FFMGF ) said Thursday that its net loss widened in the third quarter. The company reported a net loss and comprehensive loss of C$21.5 million, or a loss of $0.02 per share, in the three months ended Sept. 30, compared to a year-ago loss of $5.7 million, or a...

FRANKFURT (Reuters) -BioNTech said on Thursday that its collaboration with Pfizer ( PFE ) has not changed, when asked to comment on a report that Pfizer ( PFE ) is looking to sell its stake in the German biotech firm. We continue to have a close and strong collaboration, a spokesperson said in a statement, adding that BioNTech would not...

08:15 AM EST, 11/13/2025 (MT Newswires) -- Tidewater Renewables ( TDWRF ) on Thursday reported a narrowed net loss in the third quarter despite a fall in revenue. For the three months ended Sept. 30, net loss was $1.0 million or $0.03 loss per diluted share compared with a net loss of $367.1 million or $10.46 loss per diluted share,...